Skip to main content Accessibility help
×
Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-25T17:41:07.315Z Has data issue: false hasContentIssue false

Case 15: - The lady with bipolar disorder (BP), borderline personality disorder (BPD), and myasthenia gravis (MG)

Published online by Cambridge University Press:  03 April 2024

Nevena V. Radonjić
Affiliation:
State University of New York Upstate Medical University
Thomas L. Schwartz
Affiliation:
State University of New York Upstate Medical University
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

Which medication is least likely to precipitate a myasthenic crisis in a patient with MG?

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abualkhair, L, Almaghrabi, A, Al Edrees, N, et al. Unmasking of myasthenia gravis after introduction of oral risperidone in a schizophrenic Saudi male: a case report. Cureus 2021; 13:e20541Google Scholar
Blum, N, St John, D, Pfohl, B, et al. Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with borderline personality disorder: a randomized controlled trial and 1-year follow-up. Am J Psychiatry 2008; 165:468–78CrossRefGoogle ScholarPubMed
Bozzatello, P, Rocca, P, Baldassarri, L, et al. The role of trauma in early onset borderline personality disorder: a biopsychosocial perspective. Front Psychiatry 2021; 12; https://doi.org/10.3389/fpsyt.2021.721361CrossRefGoogle ScholarPubMed
Cattane, N, Rossi, R, Lanfredi, M, et al. Borderline personality disorder and childhood trauma: exploring the affected biological systems and mechanisms. BMC Psychiatry 2017; 17:221CrossRefGoogle ScholarPubMed
Choi-Kain, LW, Albert, EB, Gunderson, JG. Evidence-based treatments for borderline personality disorder: implementation, integration, and Stepped Care. Harv Rev Psychiatry 2016; 24:342–56CrossRefGoogle ScholarPubMed
Choi-Kain, LW, Finch, EF, Masland, SR, et al. What works in the treatment of borderline personality disorder. Curr Behav Neurosci Rep 2017; 4:2130CrossRefGoogle ScholarPubMed
Crawford, MJ, MacLaren, T, Reilly, JG. Are mood stabilisers helpful in treatment of borderline personality disorder? BMJ 2014; 349:g5378CrossRefGoogle ScholarPubMed
Goldberg, JF. Personality Disorders and Traits. Cambridge: Cambridge University Press, 2021.Google Scholar
Goodman, M, Carpenter, D, Tang, CY, et al. Dialectical behavior therapy alters emotion regulation and amygdala activity in patients with borderline personality disorder. J Psychiatr Res 2014; 57:108–16CrossRefGoogle ScholarPubMed
Gregory, RJ, Remen, AL. A manual-based psychodynamic therapy for treatment-resistant borderline personality disorder. Psychotherapy (Chic) 2008; 45:1527CrossRefGoogle ScholarPubMed
Hancock-Johnson, E, Griffiths, C, Picchioni, M. A focused systematic review of pharmacological treatment for borderline personality disorder. CNS Drugs 2017; 31:345–56CrossRefGoogle ScholarPubMed
Jordan, H, Ortiz, N. Management of insomnia and anxiety in myasthenia gravis. J Neuropsychiatry Clin Neurosci 2019; 31:386–91CrossRefGoogle ScholarPubMed
Lis, E, Greenfield, B, Henry, M, et al. Neuroimaging and genetics of borderline personality disorder: a review. J Psychiatry Neurosci 2007; 32:162–73Google ScholarPubMed
Martín-Blanco, A, Ferrer, M, Soler, J, et al. Association between methylation of the glucocorticoid receptor gene, childhood maltreatment, and clinical severity in borderline personality disorder. J Psychiatr Res 2014; 57:3440CrossRefGoogle ScholarPubMed
McGowan, PO, Sasaki, A, D’Alessio, AC, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009; 12:342–8CrossRefGoogle ScholarPubMed
Oldham, JM, Glen Gabbard, CO, Goin, MK, et al. Practice Guideline for the Treatment of Patients with Borderline Personality Disorder. Washington, DC: American Psychiatric Association 2010Google Scholar
Paris, J. Suicidality in borderline personality disorder. Medicina 2019; 55:223CrossRefGoogle ScholarPubMed
Perez-Rodriguez, MM, Bulbena-Cabré, A, Bassir Nia, A, et al. The neurobiology of borderline personality disorder. Psychiatr Clin North Am 2018; 41:633–50CrossRefGoogle ScholarPubMed
Radtke, KM, Schauer, M, Gunter, HM, et al. Epigenetic modifications of the glucocorticoid receptor gene are associated with the vulnerability to psychopathology in childhood maltreatment. Transl Psychiatry 2015; 5:e571CrossRefGoogle ScholarPubMed
Sheikh, S, Alvi, U, Soliven, B, et al. Drugs that induce or cause deterioration of myasthenia gravis: an update. J Clin Med 2021; 10:1537CrossRefGoogle ScholarPubMed
Skoglund, C, Tiger, A, Rück, C, et al. Familial risk and heritability of diagnosed borderline personality disorder: a register study of the Swedish population. Mol Psychiatry 2021; 26:9991008CrossRefGoogle ScholarPubMed
Stahl, SM. Mood Disorders and the Neurotransmitter Networks Norepinephrine and γ-Aminobutyric Acid (GABA), 5. Cambridge: Cambridge University Press, 2021, 24482Google Scholar
Starcevic, V, Janca, A. Pharmacotherapy of borderline personality disorder: replacing confusion with prudent pragmatism. Curr Opin Psychiatry 2018; 31:6973Google ScholarPubMed
Taubner, S, Volkert, J. Evidence-based psychodynamic therapies for the treatment of patients with borderline personality disorder. Clin Psychol Eur 2019; 1:120CrossRefGoogle Scholar
Thomas, N, Gurvich, C, Kulkarni, J. Borderline personality disorder, trauma, and the hypothalamus–pituitary–adrenal axis. Neuropsychiatr Dis Treat 2019; 15:2601–12CrossRefGoogle ScholarPubMed
Watanabe, Y, Hongo, S. Long-term efficacy and safety of lamotrigine for all types of bipolar disorder. Neuropsychiatr Dis Treat 2017; 13:843–54CrossRefGoogle ScholarPubMed
Witt, SH, Streit, F, Jungkunz, M, et al. Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia. Transl Psychiatry 2017; 7:e1155CrossRefGoogle ScholarPubMed
Yadav, D. Prescribing in borderline personality disorder – the clinical guidelines. Prog Neurol Psychiatry 2020; 24:2530CrossRefGoogle Scholar
Zhang, TY, Labonté, B, Wen, XL, et al. Epigenetic mechanisms for the early environmental regulation of hippocampal glucocorticoid receptor gene expression in rodents and humans. Neuropsychopharmacology 2013; 38:111–23Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×